<DOC>
	<DOCNO>NCT01997671</DOCNO>
	<brief_summary>OBJECTIVE : To evaluate impact intervention address health professional improve adequacy lipid-lowering prescription primary prevention cardiovascular disease reduce expenditure respect . DESIGN : cluster randomize clinical trial , blind ; Data obtain medical record primary care database . SETTING : 279 primary health care team Catalonia ( Spain ) , center manage Catalan Health Institute ( ICS ) SUBJECTS : Population 35 74 year , free cardiovascular disease , start lipid-lowering therapy 2 consecutive year study . INTERVENTION : Practitioners intervention group may access , whenever want computerized medical record program , personalize information assign patient start treatment cardiovascular primary prevention lipid-lowering . This information update monthly 12 consecutive months.Information present two different complementary way practitioner : asynchronous information ( patient present practitioner receive information ) synchronous information ( patient present practitioner receive information ) . VARIABLES : 1 . Primary Outcomes : - Variable RETIRA : new lipid-lowering treatment initiate year prior intervention , see inadequate withdrawn intervention period . - Variable EVITA : New lipid-lowering treatment start intervention period consider inadequate . 2 . Secondary Outcomes : - Variable COST : total cost inadequate new lipid-lowering treatment . - Variable RECORD : recording cardiovascular risk . 2.Other variable : - Principal : intervention/control group assignment health professional . - Patient variable : demographic clinical . - Professional variable : quality care indicator . STATISTICAL ANALYSIS : Descriptive analysis , agreggated health professional level , perform subsequently multilevel analysis technique use estimate effect intervention accord hierarchic data structure , particular , patient variable effect .</brief_summary>
	<brief_title>Adequacy Indication Lipid Lowering Treatment Primary Prevention</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Population 35 74 year Free cardiovascular disease Start lipidlowering therapy 2 consecutive year study Previous treatment lipidlowering History cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Primary Care</keyword>
	<keyword>Lipid-lowering therapy</keyword>
	<keyword>Prescription</keyword>
	<keyword>Adequacy</keyword>
	<keyword>Primary prevention</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Electronic Medical record</keyword>
	<keyword>Clinical Practice Guideline</keyword>
</DOC>